A Single Dose Study of SHR0410 in Healthy Male Participants

NCT03493191 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Pain

Interventions

DRUG: 0.5μg/kg SHR0410
DRUG: 1μg/kg SHR0410
DRUG: 2μg/kg SHR0410
DRUG: 5μg/kg SHR0410
DRUG: 10μg/kg SHR0410
DRUG: 20μg/kg SHR0410

Sponsor

Atridia Pty Ltd.

Collaborators

[object Object]